1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Metagen Therapeutics, Inc.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2020

Location

Tsuruoka-shi Yamagata Japan

Primary Industry

Biotechnology

About

Founded in 2020 and based in Yamanashi, Japan, Metagen Therapeutics, Inc. is a pharmaceutical company that engages in the research and development of new drugs and medical treatments using microbiome science. In March 2021, it raised JPY 90 million in seed funding from Fast Track Initiative and Keio Innovation Initiative.
Current Investors
Fast Track Initiative, Keio Innovation Initiative, JAFCO Group

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.metagentx.com
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo